KCM Clinic
| ポーランド | トルコ | オーストリア | |
| 化学療法 | から $2,000 | から $2,430 | から $2,500 |
| 食道癌化学療法 | から $4,000 | から $5,000 | から $12,000 |
| 膵臓がん化学療法 | から $4,000 | から $1,500 | から $10,000 |
| 腹腔内温熱化学療法 | から $17,000 | から $22,500 | から $40,000 |
| 脳腫瘍の化学療法 | から $4,500 | から $1,000 | から $12,000 |
Bookimedは化学療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで化学療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。化学療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。化学療法の旅路でお一人になることはありません。
Chemotherapy is free for individuals covered by Polands National Health Fund (NFZ). This includes citizens, legally employed foreigners, and Ukrainian refugees with a PESEL number. Standard drugs and hospital stays are fully reimbursed, though non-insured patients must pay for private care.
Bookimed Expert Insight: While basic chemotherapy is free, high-volume centers like European Health Center Otwock provide interdisciplinary cardio-oncology care. Choosing a specialized center can reduce risks of heart complications during treatment. Private care at facilities like KCM Clinic often bypasses the 3-6 month public waiting lists.
Patient Consensus: Many patients find public wards overcrowded and choose private care to avoid long delays. Expect to pay for side-effect medications and medical transport even within the free public system.
You typically do not need a referral to see an oncologist in Poland when booking through private medical centers. While public health systems require primary care documentation, private facilities accept patients directly for consultations, second opinions, and advanced chemotherapy treatments with existing medical records.
Bookimed Expert Insight: Private oncology centers in Poland like European Health Center Otwock often provide faster access than public systems. These facilities frequently specialize in complex cases, such as cardio-oncology. Since doctors like Andrzej Wronski work in targeted private settings, you can often secure a consultation within days by providing your digital pathology reports directly to the clinic team.
Patient Consensus: Patients value the speed of private consultations over the public referral route. Most recommend having all diagnostic scans ready to avoid delays in starting treatment.
Top centres for multi-disciplinary chemotherapy in Poland include the Maria Sklodowska-Curie National Research Institute of Oncology, University Hospital in Krakow, and the Greater Poland Cancer Centre. These institutions utilize tumor boards to integrate systemic chemotherapy with surgical oncology and radiotherapy for comprehensive patient management.
Bookimed Expert Insight: While large national institutes manage the highest patient volumes, private centers like European Health Center Otwock offer a critical advantage for complex cases. Their dedicated cardio-oncology unit specifically manages the cardiac risks of aggressive drug cycles. This level of specialization is rare and provides a safer environment for patients with pre-existing heart conditions undergoing intensive chemotherapy.
Patient Consensus: Patients often recommend regional branches like the Krakow Maria Sklodowska-Curie Institute for less bureaucracy and highly coordinated care. Many suggest joining local support groups to navigate the integrated system more efficiently.
International, non-insured patients arrange chemotherapy by coordinating directly with private oncology centers or specialized coordinators. The process requires submitting translated medical records, receiving a clinical cost estimate, and providing upfront payment. In Poland, patients often access specialized facilities like European Health Center Otwock to bypass insurance-based wait times.
Bookimed Expert Insight: While chemotherapy costs in Poland offer significant value, the biggest differentiator is specialized care. European Health Center Otwock operates Poland's only Interdisciplinary Cardio-oncology Department. This setup is vital for patients needing chemotherapy who also have underlying heart conditions, ensuring treatment safety without extra logistical hurdles.
Patient Consensus: Patients emphasize budgeting an extra 20% for supportive care or unexpected complications. Most recommend contacting private hospitals directly to ensure English-speaking support is available throughout the treatment cycle.
Poland provides access to advanced targeted therapies and immunotherapies, including FDA-approved drugs like Pembrolizumab (Keytruda) and Nivolumab (Opdivo). While the public health system offers reimbursed access for specific cancers like melanoma or lung cancer, private oncology centers and clinical trials provide faster access to the newest biological treatments.
Bookimed Expert Insight: Clinical data shows a specific pattern in Poland where private oncology centers like European Health Center Otwock often implement EMA-approved drugs 6–12 months before public reimbursement catches up. For patients with HER2-positive or EGFR+ mutations, looking into these private facilities can bypass the typical wait times associated with national health fund protocols.
Patient Consensus: Patients often report that while the latest immunotherapies are available, navigating the public system for triple-negative breast cancer or rare mutations remains challenging. Many find that participating in hospital-based clinical trials is the most effective way to secure high-cost drugs like Enhertu without long delays.
International chemotherapy packages in Poland bundle essential clinical services, including the chemo agent, oncologist consultations, and administration fees. Standard bundles typically cover 3–6 cycles of infusion with patient navigation, on-site medical interpreters, and basic supportive medications to manage side effects like nausea.
Bookimed Expert Insight: While basic packages in Poland cost $2,000 to $4,000, specialized oncology centers like European Health Center Otwock often exclude mandatory dental and heart screenings from their base price. Patients find higher success by budgeting an extra $250 to $500 for these pre-treatment safety checks, which are strictly required under European Union medical standards.
Patient Consensus: Patients value the transparency of EU-standard drug costs but often highlight that hospital stays are limited to 1–2 nights per cycle. It is common to budget extra for specialized follow-up tests or extended stays if side effects like neutropenia occur.